RecruitingNot ApplicableNCT07001059
oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound
Sponsor
Hôpital NOVO
Enrollment
190 participants
Start Date
Sep 4, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to evaluate whether the measure of the optic nerve sheath is a reliable diagnostic marker for giant cell arteritis
Eligibility
Min Age: 50 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying orbital ultrasound for people with giant cell arteritis (gca). The study is currently recruiting participants at 9 locations. People eligible for this study include aged 50 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTorbital ultrasound
orbital ultrasound at the beginning of the participation, and at 6 months after the inclusion.
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07001059
Related Trials
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
NCT071083877 locations
Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients
NCT070602746 locations
Disease Activity Monitoring in Patients With Giant Cell Arteritis Study
NCT075526367 locations
Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis
NCT072062381 location
The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis.
NCT072465771 location